3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, announced FDA Investigational Device Exemption (IDE) approval for their US...
Ceruvia Lifesciences, a leading neurotransformational medicine biopharmaceutical company today announced the submission of an IND application to begin a Phase 1, single center, randomized,...
